PDL BioPharma Inc (NASDAQ:PDLI)

6.43
BATS BZX Real-Time Price
As of 9:40am ET
 -0.07 / -1.08%
Today’s Change
6.45
Today|||52-Week Range
10.26
-16.60%
Year-to-Date

Today’s Trading

Previous close6.50
Today’s openn.a.
Day’s range-- - --
Volume652
Average volume (3 months)4,020,047
Market cap$1.1B
Dividend yield9.23%
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.5
Price/Sales2.10
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...0.000.00%
CLLSCellectis SA0.000.00%
ACHNAchillion Pharmaceut...+0.01+0.11%
ALDRAlder Biopharmaceuti...0.000.00%
Data as of 9:41am ET, 05/06/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers